Create your own CBD brand or source the very best ingredients for your products.
We have received thousands of requests for custom productions and white-label services in the last five years. Until now, we have kindly declined these inquiries and focused on scaling our own business with Formula Swiss branded products across 58 countries.
Now that we have reached significant economies of scale in the production processes, we can comfortably offer bulk and white-label production at very competitive prices without compromising the product quality in the production process.
We have established Formula Swiss Wholesale AG for this purpose and look forward to discussing, how we can support your business model.
A separate website will be established for this company shortly.
We are proud to present to you our latest CBD vaporiser.
The V10 Vaporiser is based on the latest 2021-technology, which includes smart functions like automatic low-power, over-puffing and anti-dry-burn protection.
It is slightly smaller than our latest model, but comes with increased battery capacity, life span and fast sleep-mode functionality. The V10 turns on automatically when you vape and turns off automatically when you stop using it.
The device can be easily stored in your pocket or purse and used over long periods of time without being charged. The V10 has a built-in over-heating function and will not feel warm in your hand or pocket.
The kit includes one refillable pod, charger and manual in english. Additional pods can be purchased in sets of 2 pods.
We continue to strive for a higher level of quality in our processes and final products.
After spending years improving our ingredients and product formulations, we are now focusing on improving the quality of everything, protecting our products from leaving us to arrive safely in your hands.
Last month, we added biodegradable shrink seals on all CBD bottles to eliminate any chance of potential damage or leaking to the bottles and medical pipettes during transport.
All tests so far clearly show that the products will not get damaged during long overseas transport legs in cargo planes without pressurized cargo rooms, nor if dropped from more than 200 cm height to a concrete surface etc.
However, if any product should get damaged during transport, we will replace it. Just send our customer service team pictures or videos and they will arrange the replacement for you.
We are now adding the following information to all our products:
We want to give you full transparency about the cannabinoids in our products and ensure you that you always get, what you order, and never anything less.
Our objective is to be as transparent as possible in everything we do without giving away any proprietary or confidential information about the production process.
If you have any questions or ideas for improvements, then please do not hesitate to contact us.
We have established Formula Swiss UK Ltd. as a subsidiary in North Yorkshire in the U.K. and have applied for local VAT registration.
Having a local presence in the U.K. will have many positive implications for our customers and wholesale partners.
From end of April, our customers in the U.K. will no longer have to deal with the Brexit-implications. The local custom clearing will be much faster going forward, and our customers will no longer have to pay any kind of fees, duties or VAT when receiving our products.
We will pay local VAT and import duties for all deliveries to the U.K.
We have notified the Office for Product Safety and Standards (OPSS) about all our cosmetic CBD products available to Great Britain consumers.
All our product information is available for the British authorities in the Cosmetic Product Notification Portal' or 'SCNP', a similar system as the European Union's CPNP system.
In 2022 the cultivation of medical cannabis and its sale to patients and export will become legal in Switzerland. The Council of States passed the corresponding law on March 11th, 2021.
In the future, Swiss doctors will be able to prescribe cannabis drugs directly on prescription to their patients.
The Swiss Parliament has approved an amendment to the Narcotics Act. The amendment is now ready for the final vote, but final approval is considered a formality.
Those who are dependent on cannabis medicinal products will, in future, be able to obtain them more easily from their doctors, as both chambers have decided. However, doctors remain obliged to report treatments to the Federal Office of Public Health (FOPH). Today you have to obtain an exemption from the FOPH before prescribing.
The Council of States unanimously adopted the amendment to the law. The National Council already agreed in the winter session. Compared to the Federal Council's proposal, he added that the BAG should also collect data on side effects during monitoring. The Council of States agrees with this addition.
The payment for cannabis medicines has not yet been settled, nor has insurance companies' financial contribution.
The amendment to the law also regulates the cultivation, manufacture, processing and trading of medicinal cannabis. Swissmedic will be the licensing authority.
At Formula Swiss, we will present our medical cannabis strategy for Formula Swiss Medic in the coming weeks.
We are proud to announce that we have officially established Formula Swiss Medic to develop a strong portfolio of medical cannabis products for patients.
In Denmark, we have partnered with a very experienced partner established in 1854 to develop medical cannabis products in our joint-venture Formula Swiss Medic ApS.
Together, we will collaborate with leading researchers and scientists in Scandinavia to increase our knowledge about how cannabinoids work in the human body and document the safety and effect of our products in patients through clinical research projects.
We expect the first medical cannabis products to be available to patients in Denmark through the official system before the end of 2021.
More information will follow shortly.
We have updated our About Us-page with more information about our company, mission, production, quality, studies.
You can access the page here.
Feel free to comment and send us feedback.
It was time to again count the number of countries, where our customers live.
Last time we updated the list back in 2019, we had 35 countries. Now the list have grown to 58 countries in total.
With the internet and global shipping via UPS our customers can now order from anywhere in the World and have their order delivered within a couple of days. UPS delivers within 48 days to San Diego, New York, Tokyo, Bangkok and within a couple of days inside Europe.
United Arab Emirates
Today, we have just launched two new very strong CBD oils in our webshop.
Full-spectrum CBD oil with 3.000 mg. CBD in MCT oil with natural flavour and with strawberry flavour.
The new CBD oils are available as 6 and 10 pcs. bundles as well.
Sleep disorders and insufficient sleep have a high prevalence worldwide and numbers are increasing each year costing society a fortune.
The Netherlands shows a point prevalence of 32.1% in 2016. Symptoms include poor sleep quality, non-restorative sleep, early awakenings, and difficulty initiating and maintaining sleep. More importantly but barely recognized by health professionals and the general public are the health hazards people risk by not getting enough good quality sleep.
There is an increased risk for diabetes, obesity, hypertension, coronary heart disease (CHD), stroke, mental disorders, including anxiety and depression, but also dementia suppressed immune system and death due to cancer, stroke and CHD. A relevant study carried out by RAND Corporation calculated that sleep deprivation costs 1.56-1.86% of GDP yearly in Germany and United Kingdom respectively, accounting for 13–15 Billion Euro per year in The Netherlands and 50-60 Billion Euro per year in Germany and The United Kingdom.
Researchers, attached to the University of Groningen in the Netherlands, believe that the promising values of full spectrum cannabidiol (CBD) and cannabinol (CBN) products can have calming neuroprotective and sedative effects on the central nervous system, and thus may be safe alternatives for sleep problems.
The Dutch researchers are planning a large double-blinded, randomized placebo-controlled crossover trial study on more than 300 people in The Netherlands using legal cannabis products from the Swiss cannabis producer, Formula Swiss AG, on patients with irritable bowel syndrome (IBS) and musculoskeletal pain due rheumatoid arthritis (RA).
This study will give insight into the potential benefit of cannabinoids on sleep by influencing the underlying disease mechanisms, which also positively affects disease symptoms and thus quality of life. An individual that sleeps on average less than six hours per night has a 13 per cent higher mortality risk than someone sleeping between seven and nine hours. An individual sleeping between six to seven hours per day still has a seven per cent higher mortality risk.
Improving the total amount of sleep and sleep quality will not only reduce a long list of health problems, but also improve the quality of life, because good sleep is one of the cornerstones of good health.
Further analysis showed that if total sleep time of people, who currently sleep less than 6 hours per night, would be augmented to 6-7 hours, costs would drop to 1.10% - 1.60% GDP thereby saving society 2.17–3.85 Billion Euro per year.
Addressing sleep deprivation will reduce health and work-related costs dramatically.
Contact for more information:
Drs. I. Niedlich den Herder Pathologist, medical manager, researcher email@example.com (+31) 646740912
Robin Roy Krigslund-Hansen CEO Formula Swiss AG, Blegistrasse 13, 6340 Baar, Switzerland www.formulaswiss.com (+41) 78 932 8584, firstname.lastname@example.org
As from today, we are have started a promotion offering 17-20% discount on all our CBG, CBN, CBC and Pet CBD oils bundles.
This limited-time promotion can be combined with existing promotions on our website, including subscription discounts.
As we promised you, we are launching a lot of new CBD products this year.
Today, we would like to present to you our new product line of 18 new, organic CBD skincare products made from the very best certified ingredients available.
We spent more than nine months developing all these products and are very satisfied with the results. We hope you and will love them as well.
All CBD skincare products are certified organic, vegan and hand-made. They are also officially registered in EU´s cosmetics database (CPNP).
We use premium packaging like white-glass bottles instead of plastic containers and packaging, when possible, and only use packaging material from sustainable wood production certified in Switzerland.
The new CBD skincare products contain 3 to 6 times more CBD than our previous CBD balms and creams, but are being offered at the same prices as before.
The products are now ready for immediate delivery from our warehouse.
We are currently working on a new version of our website with the objective of building a new design and structure to better accommodate many new CBD products and product categories.
While the website is being worked on, some parts of the website might not be working as usual and some links might be broken.
We sincerely apologize for any inconvenience caused by the work on our website and will do our best to finish the work in approximately 10 days from now.
We would like to share some exciting news with you.
Today, we are launching three, new CBD oils with a decarboxylation of just 60%, which ensures that the CBD oil keeps a high level of natural CBDa.
The products are available in our webshop.
CBDa stands for cannabidiolic acid, and as the name suggests, this molecule is closely related to CBD. In fact, scientists consider CBDa to be the parent molecule of CBD as it is converted to CBD through the process of decarboxylation (often through heating).
CBDa is what is known as a carboxylic acid, meaning that its structure contains a carboxyl group comprising one carbon, one hydrogen, and two oxygen atoms, commonly expressed as COOH. When you expose this molecule to high temperatures, this group breaks up to form carbon dioxide and hydrogen. What you are left with is cannabidiol (CBD).
Although to some extent this reaction happens naturally over time, the process is extremely slow. However, when you smoke or vape cannabis, you speed up the process greatly.
One of the conditions for which CBDA is offering hope is cancer, specifically breast cancer. Studies have shown that CBDa has the potential to suppress breast cancer cells and inhibit them from spreading throughout the body, a process known as metastasis.
The researchers found that exposing cancer cells to CBDa for just 48 hours downregulated the expression of an enzyme called cyclooxygenase-2 (COX-2), which is part of the inflammatory process and may play a role in as many as 40% of cases of invasive breast cancer. CBDa also appeared to influence a gene called SHARP1 (also known as BHLHE41), which has the action of inhibiting breast cancer metastasis.
Since experts estimate metastasis to be responsible for up to 90% of the deaths related to breast cancer, this finding could prove vital in improving the prognosis for patients diagnosed with this life-threatening condition.
Since CBDa appears to inhibit COX-2, it has proven anti-inflammatory properties.
Many conventional anti-inflammatory drugs work by inhibiting COX-2, and doctors commonly prescribe them in the treatment of painful conditions such as arthritis.
A study found that CBDa effectively relieved toxin and motion-induced vomiting in shrews, and reduced nausea in rats. Most significantly, these scientists suggest that CBDa could reduce nausea and vomiting even more effectively than CBD.
It appears that these potent effects are a result of CBDa enhancing the activation of 5-HT1A receptors. These receptors are designed to bind with the neurotransmitter serotonin and are prevalent in the digestive system.
More research is definitely necessary to establish the effects of CBDA on nausea and vomiting in humans. However, if proven, this treatment could offer a much needed relief to patients suffering from the side effects of chemotherapy as well as nausea related to other conditions.
There is little evidence currently available to support this use of CBDa, but some have suggested that this compound could be useful in the treatment of stress and anxiety in humans, due to many similarities with CBD.
Today, we would like to share some exciting news with you.
We just launched three, new full-spectrum CBD oils with a high concentration of the most popular and effective cannabinoids - CBG, CBN and CBC.
The products are available for ordering now.
The 10 ml bottle contains 1% CBG (100 mg), 3% CBD (300 mg) and a full spectrum of cannabinoids with less than 0.2% THC diluted in organic MCT oil.
Cannabigerol is the best-known cannabinoid after CBD and THC - and a very important one. In the hemp plant, both THC and CBD actually come from CBG.
Every cannabis farmer tries to grow cannabis strains with higher amounts of CBG because of the many benefits of the cannabinoid.
CBG is a very powerful vasodilator and has many neuroprotective benefits. As there are endocannabinoid receptors located within the eye structure, it is believed that CBG is one of the best cannabinoids for supporting glaucoma by decreasing the intraocular pressure in the eyes.
CBG may help against inflammation, colon disorders, irritable bowel, bladder dysfunctions, thyroid issues, Huntingtons Disease and inhibits abnormal cell growth etc.
Many also believe that CBG can block the receptors in the cancer cells, thus inhibiting growth of cancer cells. Read more about CBG.
The 10 ml bottle contains 1% CBN (100 mg), 3% CBD (300 mg) and a full spectrum of cannabinoids with less than 0.2% THC diluted in organic MCT oil.
In short this cannabinoid is popular for stimulating appetite, servere pain, regulate sleep, CNS disorders, neuro-inflammatory disorders, firbrosis etc. Research has shown that it is also antibacterial, anti-inflammatory and sedative.
We just published a very detailed article about CBN that we recommend you read.
The 10 ml bottle contains 1% CBC (100 mg), 4% CBD (400 mg) and a full spectrum of cannabinoids with less than 0.2% THC diluted in organic MCT oil.
Although CBC has not been proven to have a direct pain-relieving effect on its own, the cannabinoid has another characteristic: its comprehensive pharmacological properties.
Scientists tested the cannabinoid and its substances for their possible anti-inflammatory and antibacterial effects in the early 1980s. CBC can act as an antibiotic against fungal infections and can be used as an antibiotic against bacteria that no longer respond to conventional antibiotics due to increasing resistance.
CBC may help support gastrointestinal, postoperative pain, Crohn’s Disease and gut health.
We also just published a very detailed article about CBC that we recommend you read as well.
Since the beginning of March, we have been working on sourcing many million hand sanitisers and protective masks for hospitals, governments and healthcare workers all over Europe in partnership with Swiss medical supplies companies, pharmaceutical companies and producers of medical supplies.
Our strategic partnership allow us to source personal protective equipment (PPE) from trusted suppliers with CE- and FDA certification and test certification on the productions at reasonable prices. As you have probably heard in the media already, many new factories in China, Taiwan and India have started to produce personal protective equipment with fake product licenses under conditions not suitable for medical equipment.
We have temporarily setup a joint unit in Switzerland to check the quality of all incoming products to avoid issues with product quality, quantity, damage during transport and to repack into packaging translated for the target country to ensure the receiver understands the correct use of the protective equipment.
Now that the healthcare workers are well covered with personal protective equipment, we have decided to offer the products to private individuals through our webshops.
It is important in the weeks and months to come when societies start to gradually open up that everyone have access to quality personal protective equipment at affordable prices.
We have a stock of millions of different certified and licensed protective masks and more than 50.000 Liters of hand sanitisers available in our warehouse. Our prices are the lowest prices in Switzerland and we can deliver fast by UPS to any country in the World.
Please notice that the hand sanitiser produced in the United Kingdom has been effectively tested and certified against CovID-19 and other viruses.
We will add more products to the webshops as we receive them.
If you want to purchase a large quantity of products for your family, company, organisations or for donations, please contact us at email@example.com and inform us about the detailed purpose of the order and our team will evaluate it.
We do not allow anyone to resell our products and take financially advantage of the CovID-19 situation by pricing up our products, repacking them etc.
Our products are developed for private and non-medical usage only.
We continuously want to improve the customer experience with our products.
Over the last three years, we have developed more than 150 different CBD oil products and continue to come up with new formulations to cover the increasing demand for organic CBD oils.
We have been working closely with our supplier of pipettes for our CBD oils to improve the quality and value for our customers.
The new version of the pipette is even more durable and has been air pressured to not leak under any circumstances during transport on road, sea or air in pressurised and non-pressurised cargo rooms etc.
It has built-in child protection, but it is still possible to open for people with little power in their hands.
Today, we have placed an order of 1.2 million pipettes with the millilitres scale and our brand printed on the pipettes to be delivered by end of May. Very soon all our products will be with the new pipette design.
We look forward to hearing your opinion on the new pipette.
We are proud to announce that we have signed a research collaboration with the University of Bologna and their Department of Veterinary Medical Sciences for a range of studies for the effect of cannabidiol (CBD) in animals.
Professor Roberto Chiocchetti DVM, PhD. and his team from Department of Veterinary Medical Science are very well respected for their extensive veterinary medical science research and have published more than 60 publications to date.
Formula Swiss AG was founded in 2013 and now produce more than one hundred different CBD products in Switzerland for clients in 58 countries. Formula Swiss will support the research teams with products, formulations, knowledge and research funding.
With the collaboration between Professor Roberto Chiocchetti´s team of experts researchers and Formula Swiss in Switzerland, we will gain valuable knowledge about the reactions and results of cannabidiol (CBD) in animals to the benefit of not just the animals, but everyone interested in learning more about the effect of cannabinoids for animals.
The first study "Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract" is available.
Cannabinoid receptors showed a wide distribution in the feline gastrointestinal tract layers. Although not yet confirmed/supported by functional evidences, the present research might represent an anatomical substrate potentially useful to support, in feline species, the therapeutic use of cannabinoids during gastrointestinal inflammatory diseases.
The next study will be CBD for horses followed by several other studies of the effect of CBD for different animals.
The Coronavirus pandemic has caused a global explosion in demand for medical supplies and in particular for medical-grade hand sanitisers for hospitals, clinics and private households.
The global supply is currently very limited and as such prices have gone through the roof as it is very challenging to source large quantities of ethanol for the extraction. Furthermore, the sourcing and transport of the product containers and packaging have become increasingly difficult.
As we have a large extraction capability, we have worked together with a highly respective pharmaceutical company specialising in producing medicinal products in Switzerland. We have worked closely together to produce a steril antiseptic gel with 70% ethanol.
The new hand sanitiser product is licensed in Switzerland at BAV and throughly tested with a documented effect against standard bacteria, H1N1 flu etc. We have received numerous expert opinions on the quality and effect.
We are offering this product in our webshops at very fair prices for everyone.
We kindly ask that you purchase for you and your family only. We will reject purchase orders for large quantities.
We will be donating steril antiseptic gel to hospitals in Switzerland and Romania. We will also make donations to people in need.
Thank you for your understanding.
We hope you, your family and friends are safe.
We have have been closely monitoring the ongoing COVID-19 virus situation develop from bad to worse over the past few weeks. In keeping with the guidelines from Swiss government authorities, we have taken several measures to avoid contributing to the spread of the infection within the company, as well as to avoid any production or delivery disruptions.
We can confirm that we remain fully operational during our business hours.
The Swiss government have decided to close all schools, stores and prohibit more than 5 people meeting at a time for now at least until April 4th.
All Swiss borders are closed with immediate effect for all non-urgent or private visits to Switzerland for six months.
Internally, we have taken a number of measures, technically and logistically, to deal with the emerging challenges:
Many employees have to work from home due to the change in family situation, but everyone will be working 100% and our fulfilment team will stay intact and continue to send out thousands of orders every day.
UPS confirmed that they will continue to ship globally and deliver locally within the guaranteed delivery times in all areas including Italy.
Externally, we have sourced a large supply of biomass, filters, bottles, packaging (except for our graduated pipettes), printers, toner, paper etc. to prepare for a situation like this.
We hope to stay operational for as long as possible during the Corona-virus and until the crisis subsides.
Together with our friends in the pharmaceutical industry we are also producing more than 200.000 pcs. of medical graded hand sanitisers and 500.000 pcs. of disposable protection masks under our brand and GMP-license. Starting from this week, these emergency products will be sold at prices below market level and donated to hospitals and institutions in need.
We will keep you informed of developments on our side.
We recommend anyone, who possible can, to stay inside for a couple of weeks with your loved ones. Focus on your body and mind. Try to boost your immune system with healthy food, plenty of sleep, CBD and supplements.
All of us at Formula Swiss